# Ernexa Therapeutics Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/ernexa-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 24 | | Claims under review | 1 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-13T04:48:01.003077+00:00 | | Last reviewed | 2026-10-13T04:48:01.003077+00:00 | ## Identity - Legal name: Ernexa Therapeutics Inc. - Display name: Ernexa Therapeutics Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-13T13:21:56.759692+00:00 | | Completeness | 0.409 | | Record Quality | 0.827 | | Directors | 5 | | Committees | 5 | | Governance events | 12 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Elena Ratner: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:leadership_role:5 - James Bristol: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:leadership_role:6 - Peter Cicala: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:leadership_role:7 - Sanjeev Luther: Director. Status: current. Independent: false. Since: 2024-01-01. claim_id=alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:leadership_role:8 - William Wexler: Director. Status: current. Independent: true. Since: 2022-01-01. Committees: Audit (chair); Audit · Chair; Compensation · Chair; Nominating and Governance (member); Compensation (chair); Nominating and Governance (member). claim_id=alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:leadership_role:9 ## Committees - Audit (audit). Chair: William Wexler. Members: William Wexler (chair, current); James Bristol (member, current); Peter Cicala (member, current). committee_id=alpha:committee:ernexa-therapeutics-inc:audit - Audit · Chair; Compensation · Chair; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: William Wexler (member, current). committee_id=alpha:committee:ernexa-therapeutics-inc:audit-chair-compensation-chair-nominating-and-governance - Audit; Compensation; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: James Bristol (member, current); Peter Cicala (member, current). committee_id=alpha:committee:ernexa-therapeutics-inc:audit-compensation-nominating-and-governance - Compensation (compensation). Chair: William Wexler. Members: William Wexler (chair, current); James Bristol (member, current); Peter Cicala (member, current). committee_id=alpha:committee:ernexa-therapeutics-inc:compensation - Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: James Bristol (member, current); Peter Cicala (member, current); William Wexler (member, current). committee_id=alpha:committee:ernexa-therapeutics-inc:nominating-and-governance ## Executive leadership - Sandra Gurrola: Senior Vice President, Finance. Status: current. claim_id=alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:leadership_role:10 - Sanjeev Luther: President and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:leadership_role:11 ## Governance events - EXECUTIVE_APPOINTED: Sandra Gurrola executive of Ernexa Therapeutics Inc., effective 2026-03-13. Effective: 2026-03-13. Detected: 2026-10-13T04:48:01.003077+00:00. event_id=alpha:event:transition:1ug6c531yczqjr - CEO_CHANGED: Sanjeev Luther executive of Ernexa Therapeutics Inc., effective 2026-03-13. Effective: 2026-03-13. Detected: 2026-10-13T04:48:01.003077+00:00. event_id=alpha:event:transition:1p9j9j913k9wnf - DIRECTOR_APPOINTED: Elena Ratner seat on Ernexa Therapeutics Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-13T04:48:01.003077+00:00. event_id=alpha:event:transition:16i7e0pxqiww - DIRECTOR_APPOINTED: Peter Cicala seat on Ernexa Therapeutics Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-13T04:48:01.003077+00:00. event_id=alpha:event:transition:1jy4zyv12eyxgb - DIRECTOR_APPOINTED: Sanjeev Luther seat on Ernexa Therapeutics Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-13T04:48:01.003077+00:00. event_id=alpha:event:transition:1rooele5rd8a8 - COMMITTEE_MEMBER_ADDED: Peter Cicala member of Audit; Compensation; Nominating and Governance, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-13T04:48:01.003077+00:00. event_id=alpha:event:transition:ckl5jf1h5l611 - DIRECTOR_APPOINTED: James Bristol seat on Ernexa Therapeutics Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-13T04:48:01.003077+00:00. event_id=alpha:event:transition:mi4nj91930gr1 - COMMITTEE_CREATED: Audit; Compensation; Nominating and Governance committee of Ernexa Therapeutics Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-13T04:48:01.003077+00:00. event_id=alpha:event:transition:1v6be6f1ebe5sh - COMMITTEE_MEMBER_ADDED: James Bristol member of Audit; Compensation; Nominating and Governance, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-13T04:48:01.003077+00:00. event_id=alpha:event:transition:1ozissfuy1o6v - DIRECTOR_APPOINTED: William Wexler seat on Ernexa Therapeutics Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-13T04:48:01.003077+00:00. event_id=alpha:event:transition:xgzscf143n7v7 - COMMITTEE_CREATED: Audit · Chair; Compensation · Chair; Nominating and Governance committee of Ernexa Therapeutics Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-13T04:48:01.003077+00:00. event_id=alpha:event:transition:1h1dktvmt5noz - COMMITTEE_MEMBER_ADDED: William Wexler member of Audit · Chair; Compensation · Chair; Nominating and Governance, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-13T04:48:01.003077+00:00. event_id=alpha:event:transition:1vf0sxnyhr59x ## Scoped resources - `alpha://company/ernexa-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record - `alpha://company/ernexa-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=identity - `alpha://company/ernexa-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/ernexa-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=board - `alpha://company/ernexa-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=committees - `alpha://company/ernexa-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=leadership - `alpha://company/ernexa-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=ownership - `alpha://company/ernexa-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=financials - `alpha://company/ernexa-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/ernexa-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=compensation - `alpha://company/ernexa-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=governance - `alpha://company/ernexa-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/ernexa-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=audit - `alpha://company/ernexa-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=legal - `alpha://company/ernexa-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=risk - `alpha://company/ernexa-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=cyber - `alpha://company/ernexa-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/ernexa-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=agents - `alpha://company/ernexa-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/ernexa-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=events - `alpha://company/ernexa-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=relationships - `alpha://company/ernexa-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=assessments - `alpha://company/ernexa-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:committee_appointment:13: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:william-wexler","name":"William Wexler"},"source_id":"board_seats"}` - Claim alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:james-bristol","name":"James Bristol"},"source_id":"board_seats"}` - Claim alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:peter-cicala","name":"Peter Cicala"},"source_id":"board_seats"}` - Claim alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:william-wexler","name":"William Wexler"},"source_id":"board_seats"}` - Claim alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:james-bristol","name":"James Bristol"},"source_id":"board_seats"}` - Claim alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:peter-cicala","name":"Peter Cicala"},"source_id":"board_seats"}` - Claim alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:james-bristol","name":"James Bristol"},"source_id":"board_seats"}` - Claim alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:peter-cicala","name":"Peter Cicala"},"source_id":"board_seats"}` - Claim alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:william-wexler","name":"William Wexler"},"source_id":"board_seats"}` ## Leadership - Elena Ratner: Director. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:leadership_role:5. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b54259ae49f308f87b81c50012ad63294a5d51122f31f6d4ed85b59a548da3a5. - James Bristol: Director, Audit; Compensation; Nominating and Governance. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:leadership_role:6. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b54259ae49f308f87b81c50012ad63294a5d51122f31f6d4ed85b59a548da3a5. - Peter Cicala: Director, Audit; Compensation; Nominating and Governance. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:leadership_role:7. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b54259ae49f308f87b81c50012ad63294a5d51122f31f6d4ed85b59a548da3a5. - Sanjeev Luther: Director. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:leadership_role:8. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b54259ae49f308f87b81c50012ad63294a5d51122f31f6d4ed85b59a548da3a5. - William Wexler: Director, Audit · Chair; Compensation · Chair; Nominating and Governance. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:leadership_role:9. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b54259ae49f308f87b81c50012ad63294a5d51122f31f6d4ed85b59a548da3a5. - Sandra Gurrola: Senior Vice President, Finance. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:leadership_role:10. Valid from: 2026-03-13. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:89da981f5bf3c0317061b380a01f7b17e05d579343511b38d08e4c8eae6caa90. - Sanjeev Luther: President and Chief Executive Officer. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:leadership_role:11. Valid from: 2026-03-13. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b337a3b7312644afe15474831eb2ebc618129f18211345001ed69b4210479206. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair William Wexler; Members William Wexler (Chair); James Bristol; Peter Cicala. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:committee_record:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1c63e4a2dfdf355834d653429e854a3a618d70213b73c50bbe9f12e409b102e. - Compensation: Chair William Wexler; Members William Wexler (Chair); James Bristol; Peter Cicala. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1c63e4a2dfdf355834d653429e854a3a618d70213b73c50bbe9f12e409b102e. - Nominating and Governance: Chair not stated; Members James Bristol; Peter Cicala; William Wexler. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1c63e4a2dfdf355834d653429e854a3a618d70213b73c50bbe9f12e409b102e. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Ernexa Therapeutics Inc.. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3c2169ed0a70b266374ca0030ed5346bc217f5c0f7eec620d5f6fd1bc0b62c7b. ## Entity Status - Public listing published. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3c2169ed0a70b266374ca0030ed5346bc217f5c0f7eec620d5f6fd1bc0b62c7b. ## Published Fact - US. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3c2169ed0a70b266374ca0030ed5346bc217f5c0f7eec620d5f6fd1bc0b62c7b. ## Committee Appointment - William Wexler: chair, Audit. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:committee_appointment:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1c63e4a2dfdf355834d653429e854a3a618d70213b73c50bbe9f12e409b102e. - James Bristol: member, Audit. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1c63e4a2dfdf355834d653429e854a3a618d70213b73c50bbe9f12e409b102e. - Peter Cicala: member, Audit. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1c63e4a2dfdf355834d653429e854a3a618d70213b73c50bbe9f12e409b102e. - William Wexler: chair, Compensation. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1c63e4a2dfdf355834d653429e854a3a618d70213b73c50bbe9f12e409b102e. - James Bristol: member, Compensation. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1c63e4a2dfdf355834d653429e854a3a618d70213b73c50bbe9f12e409b102e. - Peter Cicala: member, Compensation. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1c63e4a2dfdf355834d653429e854a3a618d70213b73c50bbe9f12e409b102e. - James Bristol: member, Nominating and Governance. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1c63e4a2dfdf355834d653429e854a3a618d70213b73c50bbe9f12e409b102e. - Peter Cicala: member, Nominating and Governance. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1c63e4a2dfdf355834d653429e854a3a618d70213b73c50bbe9f12e409b102e. - William Wexler: member, Nominating and Governance. Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a1c63e4a2dfdf355834d653429e854a3a618d70213b73c50bbe9f12e409b102e. ## Security Listing - ERNA (NASDAQ). Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:security_listing:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3c2169ed0a70b266374ca0030ed5346bc217f5c0f7eec620d5f6fd1bc0b62c7b. - ERNAW (NASDAQ). Claim: alpha:claim:company:d78f7bcb-4075-4c70-a63f-69722d4b91bc:security_listing:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3c2169ed0a70b266374ca0030ed5346bc217f5c0f7eec620d5f6fd1bc0b62c7b. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:3c2169ed0a70b266374ca0030ed5346bc217f5c0f7eec620d5f6fd1bc0b62c7b: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/ernexa-therapeutics-inc). - alpha:projection-evidence:document:b54259ae49f308f87b81c50012ad63294a5d51122f31f6d4ed85b59a548da3a5: [Ernexa Therapeutics Inc. DEF 14A 2025-04-14](https://www.sec.gov/Archives/edgar/data/748592/000164117225004585/formdef14a.htm). - alpha:projection-evidence:document:89da981f5bf3c0317061b380a01f7b17e05d579343511b38d08e4c8eae6caa90: [ERNA 10-K executive officers](https://www.sec.gov/Archives/edgar/data/748592/000149315226010102/form10-k.htm). - alpha:projection-evidence:document:b337a3b7312644afe15474831eb2ebc618129f18211345001ed69b4210479206: [ERNA 10-K executive officers](https://www.sec.gov/Archives/edgar/data/748592/000149315226010102/form10-k.htm). - alpha:projection-evidence:a1c63e4a2dfdf355834d653429e854a3a618d70213b73c50bbe9f12e409b102e: [Audit](https://www.sec.gov/Archives/edgar/data/748592/000164117225004585/formdef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/ernexa-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/ernexa-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/ernexa-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/ernexa-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-13T13:21:56.57339+00:00; recorded 2026-10-13T13:21:56.57339+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.